# Sutro Biopharma, Inc.: Form 8-K, filed Jun 15, 2020

- Company: [Sutro Biopharma, Inc.](/companies/stro.md) (CIK 1382101)
- Form: 8-K
- Filed: 2020-06-15
- Accepted by EDGAR: Jun 15, 2020, 07:21 ET
- Period: 2020-06-15
- Accession: 0001564590-20-029235
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1382101/000156459020029235/stro-8k_20200615.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1382101/000156459020029235/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1382101/000156459020029235/stro-8k_20200615.htm

Filed Jun 15, 2020.
Source: SEC EDGAR, the filing index for accession 0001564590-20-029235. Last ingested by Listed: Nov 9, 2026, 23:14 ET. No prices; not investment advice.